(Q36523002)

English

Case report: Transient success using prolonged treatment with miltefosine for a patient with diffuse cutaneous leishmaniasis infected with Leishmania mexicana mexicana.

scientific article published on 12 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

0 references

Case report: Transient success using prolonged treatment with miltefosine for a patient with diffuse cutaneous leishmaniasis infected with Leishmania mexicana mexicana (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

ChEBI release 2020-05-28

cutaneous leishmaniasis

1 reference

based on heuristic

inferred from title

Leishmania mexicana

object named as

Leishmania mexicana

1 reference

based on heuristic

inferred from title

Ana Arana-Guajardo

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Alejandro Ordaz-Farias

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Fania Z Muñoz-Garza

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Farah K Sevilla-Gonzalez

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jorge Ocampo-Candiani

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Nancy Treviño-Garza

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Ingeborg Becker

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Adrian Camacho-Ortiz

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

0 references

publication date

12 December 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

number of pages

4

1 reference

based on heuristic

inferred from page(s)

American Journal of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

88

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

153-156

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Advances in the treatment of cutaneous leishmaniasis in the new world in the last ten years: a systematic literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541727

30 September 2017

Improved treatment of visceral leishmaniasis (kala-azar) by using combination of ketoconazole, miltefosine with an immunomodulator-Picroliv

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541727

30 September 2017

CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541727

30 September 2017

Current diagnosis and treatment of visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541727

30 September 2017

Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541727

30 September 2017

New antileishmanial candidates and lead compounds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541727

30 September 2017

Combination therapy for visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541727

30 September 2017

Increase of NK cells and proinflammatory monocytes are associated with the clinical improvement of diffuse cutaneous leishmaniasis after immunochemotherapy with BCG/Leishmania antigens.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541727

30 September 2017

CD8 cytotoxic T cells in cutaneous leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541727

30 September 2017

Prevention and control of leishmaniasis vectors: current approaches

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541727

30 September 2017

Eight cases of feline cutaneous leishmaniasis in Texas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541727

21 September 2018

Cutaneous leishmaniasis in Texas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541727

21 September 2018

A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541727

21 September 2018

Evaluation of meglumine antimoniate effects on liver, kidney and pancreas function tests in patients with cutaneous leishmaniasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541727

21 September 2018

Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541727

21 September 2018

Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541727

21 September 2018

Disseminated Leishmaniasis: A New and Emerging Form of Leishmaniasis Observed in Northeastern Brazil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541727

21 October 2018

Disseminated anergic cutaneous leishmaniasis. An autochthonous case in Texas and the Mexican states of Tamaulipas and Nuevo Leon

1 reference

https://pubmed.ncbi.nlm.nih.gov/23243111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/23243111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Bolivian mucosal leishmaniasis with miltefosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/23243111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutaneous leishmaniasis in Texas: A northern spread of endemic areas

1 reference

https://pubmed.ncbi.nlm.nih.gov/23243111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23243111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4269/AJTMH.2012.11-0592

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23243111%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36523002&oldid=1899000495"